Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 4 Date: 15 Aug 2024
Reviewer:  Gustavo Nari
Reviewer's report:
Dear authors, I have read the paper with great interest, the previous reviewers have made
excellent contributions and I note that they have included them in the paper. I consider that
the weaknesses of the study and as mentioned are the low number of cases and that it is a
retrospective study. In any case, the authors state that they are preparing multicenter studies in
this sense.
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 4 Date: 15 Aug 2024
Reviewer:  Gustavo Nari
Reviewer's report:
Dear authors, I have read the paper with great interest, the previous reviewers have made
excellent contributions and I note that they have included them in the paper. I consider that
the weaknesses of the study and as mentioned are the low number of cases and that it is a
retrospective study. In any case, the authors state that they are preparing multicenter studies in
this sense.
Please review this paper.
user
Title: Is DEB-TACE  as  locoregional  therapy  before  liver  transplantation  for  hepatocellular
  carcinoma effective?
Version: 4 Date: 15 Aug 2024
Reviewer:  Gustavo Nari
Reviewer's report:
Dear authors, I have read the paper with great interest, the previous reviewers have made
excellent contributions and I note that they have included them in the paper. I consider that
the weaknesses of the study and as mentioned are the low number of cases and that it is a
retrospective study. In any case, the authors state that they are preparing multicenter studies in
this sense.
assistant